Head-to-head · WeighScore
Fitstry vs Strut Health
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 61.5/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Fitstry | Strut Health |
|---|---|---|
| WeighScore | 61.5/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #329 | #28 |
| Semaglutide | $179/mo (annual plan, plus a separate fee, compounded) | Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal |
| Tirzepatide | $269/mo (annual plan, compounded) | Oral $199/30 days; injection $219/mo—confirm prescribed dose, quantity and renewal |
| Coverage | Coverage not published | FAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #329 · C
Strengths
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
- Runs under Weightstry, LLC, a LegitScript-certified practice, with a named support email and phone
- Full compounded lineup — weekly injection, daily oral tablet and microdosing options
What to consider
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
- Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Site position #28 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
- Provider consultations, follow-ups and shipping are advertised as included
- Current help describes an account cancellation button; terms also provide an email route
- Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription
What to consider
- Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
- Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
- 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
- Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024
Featured provider
Strut Health
Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.